JP2013516482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013516482A5 JP2013516482A5 JP2012548137A JP2012548137A JP2013516482A5 JP 2013516482 A5 JP2013516482 A5 JP 2013516482A5 JP 2012548137 A JP2012548137 A JP 2012548137A JP 2012548137 A JP2012548137 A JP 2012548137A JP 2013516482 A5 JP2013516482 A5 JP 2013516482A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dexmedetomidine
- pharmaceutically acceptable
- pharmaceutical composition
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29344010P | 2010-01-08 | 2010-01-08 | |
| US61/293,440 | 2010-01-08 | ||
| PCT/US2011/020462 WO2011085162A2 (en) | 2010-01-08 | 2011-01-07 | Topical transdermal dexmedetomidine compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013516482A JP2013516482A (ja) | 2013-05-13 |
| JP2013516482A5 true JP2013516482A5 (enExample) | 2014-02-27 |
Family
ID=44306157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012548137A Pending JP2013516482A (ja) | 2010-01-08 | 2011-01-07 | 局所経皮用デクスメデトミジン組成物およびそれらの使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20130072532A1 (enExample) |
| EP (1) | EP2521544A4 (enExample) |
| JP (1) | JP2013516482A (enExample) |
| CN (1) | CN102753169A (enExample) |
| AU (1) | AU2011204315A1 (enExample) |
| CA (1) | CA2786598A1 (enExample) |
| MX (1) | MX2012007933A (enExample) |
| NZ (2) | NZ703808A (enExample) |
| RU (1) | RU2012133969A (enExample) |
| WO (1) | WO2011085162A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201604653TA (en) * | 2011-12-11 | 2016-07-28 | Recro Pharma Inc | Intranasal dexmedetomidine compositions and methods of use thereof |
| ES2765264T3 (es) * | 2013-05-06 | 2020-06-08 | Allergan Inc | Agonistas alfa-adrenérgicos para el tratamiento de traumatismo tisular |
| RU2646512C2 (ru) * | 2013-10-07 | 2018-03-05 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Устройства для трансдермальной доставки дексмедетомидина и способы их применения |
| RU2648817C2 (ru) * | 2013-10-07 | 2018-03-28 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Способы и композиции для лечения абстинентных синдромов с использованием неседативных трансдермальных композиций на основе дексмедетомидина |
| CN105764496B (zh) * | 2013-10-07 | 2020-09-25 | 帝国制药美国公司 | 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物 |
| CA2924188C (en) * | 2013-10-07 | 2018-12-18 | Teikoku Pharma Usa, Inc. | Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions |
| TWI709417B (zh) | 2013-10-07 | 2020-11-11 | 美商帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
| MA41689A (fr) * | 2014-10-15 | 2017-08-22 | Bioxcel Corp | Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine |
| CA3038354C (en) * | 2016-10-31 | 2021-08-17 | Teikoku Pharma Usa, Inc. | Methods of managing pain using dexmedetomidine transdermal delivery devices |
| PT3562486T (pt) | 2016-12-31 | 2024-06-12 | Bioxcel Therapeutics Inc | Uso de dexmedetomidina sublingual para o tratamento da agitação |
| CN107929234B (zh) * | 2017-12-25 | 2021-07-23 | 温州医科大学附属第一医院 | 一种应用于烧伤创面修复的外用制剂膏体 |
| IL279713B2 (en) | 2018-06-27 | 2025-01-01 | Bioxcel Therapeutics Inc | Dexmedetomidine-containing layer compositions and methods for their production |
| WO2020176807A1 (en) | 2019-02-27 | 2020-09-03 | Vanderbilt University | Methods of treating trigeminal nerve pain |
| US20220211672A1 (en) | 2019-05-01 | 2022-07-07 | Clexio Biosciences Ltd. | Methods of treating pruritus |
| MX2021012824A (es) | 2019-05-01 | 2022-10-19 | Clexio Biosciences Ltd | Métodos para tratar el prurito. |
| JP7739256B2 (ja) | 2019-07-19 | 2025-09-16 | バイオエクセル セラピューティクス，インコーポレイテッド | 鎮静作用のないデクスメデトミジン治療レジメン |
| CN113577556A (zh) * | 2021-08-01 | 2021-11-02 | 武汉左点科技有限公司 | 一种用于阴道康复治疗的生物反馈电刺激方法及装置 |
| CN117582424A (zh) * | 2022-08-17 | 2024-02-23 | 宜昌人福药业有限责任公司 | 右美托咪定经皮组合物、透皮贴剂及其制备方法和应用 |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5124157A (en) * | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
| US5217718A (en) * | 1989-08-18 | 1993-06-08 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
| FI894911A0 (fi) * | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
| GB9111732D0 (en) * | 1991-05-31 | 1991-07-24 | Orion Yhtymae Oy | The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs |
| GB9913677D0 (en) * | 1999-06-11 | 1999-08-11 | Imperial College | Formulation |
| AUPR184500A0 (en) * | 2000-12-01 | 2001-01-04 | Drug Delivery Solutions Pty Ltd | Dispensing device |
| US20030022926A1 (en) * | 2001-05-07 | 2003-01-30 | Lavand'homme Patricia | Method for treating neuropathic pain and pharmaceutical preparation therefor |
| IL147921A0 (en) * | 2002-01-31 | 2002-08-14 | Abdulrazik Mohammad | A method for treating central nervous system disorders by ocular dosing |
| US20050058696A1 (en) * | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| GB0611241D0 (en) * | 2006-06-07 | 2006-07-19 | Daniolabs Ltd | The treatment of increased sebum production |
-
2011
- 2011-01-07 NZ NZ703808A patent/NZ703808A/en not_active IP Right Cessation
- 2011-01-07 NZ NZ601195A patent/NZ601195A/en not_active IP Right Cessation
- 2011-01-07 MX MX2012007933A patent/MX2012007933A/es not_active Application Discontinuation
- 2011-01-07 CA CA2786598A patent/CA2786598A1/en not_active Abandoned
- 2011-01-07 EP EP11732180.2A patent/EP2521544A4/en not_active Withdrawn
- 2011-01-07 AU AU2011204315A patent/AU2011204315A1/en not_active Abandoned
- 2011-01-07 US US13/520,959 patent/US20130072532A1/en not_active Abandoned
- 2011-01-07 CN CN2011800088869A patent/CN102753169A/zh active Pending
- 2011-01-07 JP JP2012548137A patent/JP2013516482A/ja active Pending
- 2011-01-07 WO PCT/US2011/020462 patent/WO2011085162A2/en not_active Ceased
- 2011-01-07 RU RU2012133969/15A patent/RU2012133969A/ru not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013516482A5 (enExample) | ||
| RU2012133969A (ru) | Локальные трансдермальные композиции дексмедетомидина и способы их применения | |
| CN111565716B (zh) | 使用地匹福林的方法 | |
| JP5902628B2 (ja) | 相乗的抗ウイルス組成物及びその使用 | |
| CA2883751A1 (en) | Methods of treating alzheimer's disease and pharmaceutical compositions thereof | |
| JP2008044951A5 (enExample) | ||
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| JP2015513309A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| EA201590166A8 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| ES3029560T3 (en) | 5-amino-2,3-dihydro-1,4-phthalazinedione as glucocorticoid-sparing agent | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| IL318427A (en) | Varenicline compound for use as a medication for treating dry eye, increasing tear production and treating eye discomfort and a pramipexole preparation containing varenicline | |
| JP2012525358A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| EA201591768A1 (ru) | Дозированные препараты в качестве модуляторов опиоидного рецептора | |
| IL194500A0 (en) | Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application | |
| JP2019516797A5 (enExample) | ||
| JP6659819B2 (ja) | 化学療法に関連する脱毛の軽減方法 | |
| RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
| CN115551515A (zh) | 靶向3CLpro的连翘苷及其衍生物和抗新冠应用 | |
| CN102596194A (zh) | 组合药物 | |
| JP7634002B2 (ja) | 新規小児用配合剤 | |
| US20200237544A1 (en) | Topical treatment for anorectal disorders with and without seat cushion | |
| RU2012114097A (ru) | Терапевтический агент против хронической боли |